| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.034 | 0.9 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |